Pharmacokinetic Properties of Lorcaserin in Obese or Overweight Elderly Subjects

Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions

NCT04651881 ·Status: UNKNOWN ·Phase: PHASE1

Pharmacokinetics of LCQ908 in Patients With Renal Impairment

NCT01558323 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1 Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Hepatic Function

NCT02372084 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics and Safety of Single Subcutaneous Pasireotide (SOM230) in Subjects With Varying Degrees of Hepatic Function

NCT00698464 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of Telavancin in Normal and Obese Subjects

NCT02753855 ·Status: COMPLETED ·Phase: PHASE1

Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Balcinrenone

NCT06388616 ·Status: COMPLETED ·Phase: PHASE1

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-385 in Healthy Volunteers

NCT04075643 ·Status: COMPLETED ·Phase: PHASE1

Study of the Tolerability, Pharmacokinetics, and Pharmacodynamics of INS50589 Intravenous Infusion in Healthy Volunteers

NCT00099450 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Adverse Events and How Oral Emraclidine Moves Through the Body of Healthy Elderly Adult Participants

NCT07219030 ·Status: RECRUITING ·Phase: PHASE1

A Study to Assess Food Effect on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers

NCT01007409 ·Status: COMPLETED ·Phase: PHASE1

A Pharmacokinetic Study of MIN-101 and Its Metabolites in Healthy Subjects to Compare MIN-101 in Poor and Extensive Metabolizers

NCT03072056 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1801 in Healthy Subjects

NCT03826641 ·Status: COMPLETED ·Phase: PHASE1

Phase 1 PK Study to Evaluate the PK of CIN-107 in Subjects With Hepatic Impairment

NCT05961397 ·Status: COMPLETED ·Phase: PHASE1

Effect of Hepatic Impairment on LDK378 Pharmacokinetics

NCT01950481 ·Status: COMPLETED ·Phase: PHASE1

The Effect of Hepatic Impairment on Aprocitentan Pharmacokinetics

NCT04252495 ·Status: COMPLETED ·Phase: PHASE1

Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)

NCT04083846 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of Nilotinib in Subjects With Impaired Hepatic Function and Healthy Subjects With Normal Hepatic Function

NCT00418626 ·Status: COMPLETED ·Phase: PHASE1

A PK and Safety Study in Subjects With Hepatic Impairment

NCT01431833 ·Status: COMPLETED ·Phase: PHASE1

Study to Assess the Effect of Food on a Single Dose of Acoramidis in Healthy Adult Participants

NCT04958135 ·Status: COMPLETED ·Phase: PHASE1

Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)

NCT04083872 ·Status: COMPLETED ·Phase: PHASE1

Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions

NCT04678388 ·Status: UNKNOWN ·Phase: PHASE1

Pharmacokinetics of Ceftaroline in Normal and Obese Subjects

NCT01648127 ·Status: COMPLETED ·Phase: PHASE1

Effect Of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of PF-06865571 In Subjects With Hepatic Impairment and in Healthy Subjects

NCT04091061 ·Status: COMPLETED ·Phase: PHASE1

Compare the Pharmacokinetics and Safety of CKD-391

NCT04354987 ·Status: COMPLETED ·Phase: PHASE1

ABSK091 Food Effect Study in Healthy Subjects

NCT05533788 ·Status: COMPLETED ·Phase: PHASE1